Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Treating chronic hand eczema costs about the same in statutory and occupational health insurances in Germany, but work-related cases may lead to higher indirect costs due to longer work absences.

This study observed that patients with alopecia areata often have comorbidities and experience significant healthcare costs, with treatments like systemic therapies being infrequently used.

This paper discusses the introduction and advantages of an Insurance-Based Billing Model for scalp cooling devices in the USA, which can enhance access to this treatment for reducing chemotherapy-induced alopecia, particularly benefiting underserved and disadvantaged populations.

In this study, most surveyed physicians were aware of the meningioma risk linked to cyproterone acetate monotherapy, but many did not recall receiving updated safety communications.

This study estimates the total cost of evaluating and treating polycystic ovary syndrome in reproductive-aged women in the United States to be $4.36 billion, suggesting more liberal screening could be beneficial.

This study observed a strong overall reduction in the use of CPA/EE in the Netherlands, despite similar proportions of users with acne or other hyperandrogenic conditions before and after the referral procedure.

This article examines the PCPT study on whether daily finasteride can reduce prostate cancer incidence, describing its methodology and findings but reporting no new clinical results.

This review discusses the potential conflicts of interest and quality concerns associated with direct-to-consumer teledermatology platforms and reports no new experimental results.

In this study, researchers found that in Germany, orphan drugs with a phase III study and no comparable treatments available tend to receive higher HTA scores. There was no significant correlation between HTA scores and orphan drug prices or discount rates.

This review highlights the inconsistent and often insufficient global coverage of cranial prostheses for medical hair loss, with variations depending on healthcare system models and a general lack of standardized recognition as medically necessary devices.

In this study, individuals with alopecia areata in the UK incurred significant costs for managing their condition, with those experiencing more severe symptoms and lower disposable income facing higher financial burdens.

This report describes the use of compounded topical preparations to treat two severe psoriasis patients and calls for further studies on their regulation, protocol, and stability evaluation.

This survey study reported the pricing, formulation, and delivery options for compounded topical alopecia medications in the tri-state area, finding varied costs and noting the capability of most pharmacies to exceed commercially available minoxidil concentrations and offer delivery services.

Cataract surgery guidelines vary across Europe, and generic finasteride sales for hair loss have grown due to pill splitting.

This study estimated the economic burden of alopecia areata in Romania for 2022, finding costs of 46.289 million EUR for adult and 1.89 million EUR for pediatric cases.

This study found that insurance coverage for cranial hair prostheses in patients with alopecia areata is generally inadequate, adding to their financial and psychological burdens.

This study found that patients, oncologists, and payers prioritize a significant improvement in efficacy to justify the added risks and costs when considering CDK4/6 inhibitors combined with endocrine therapy for early-stage breast cancer.

In this study, a survey in Norway and Sweden among adults with self-reported alopecia areata revealed a substantial economic burden with annual mean costs of €7,677 in Norway and €12,582 in Sweden, largely due to indirect costs from reduced productivity.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

This study found that men with vertex type androgenetic alopecia had higher triglyceride levels and lower HDL cholesterol levels compared to those with normal hair, suggesting it may be a marker of hyperlipidemia.

This article discusses the approval and perceived potential of Provenge, a new prostate cancer vaccine, highlighting its capability to extend survival in certain patients while also noting ongoing debates about its cost and mechanisms; it reports no new clinical results.

This study observed that 2% minoxidil solution stopped hair loss and promoted new hair growth in 85% of female pattern androgenetic alopecia patients, while 2% progesterone solution achieved similar results in 71% of patients.

This study found that individuals with alopecia areata in the UK, particularly women and those of Asian ethnicity with lower income and severe symptoms, spent a significant portion of their disposable income on managing the condition, highlighting wigs and private dermatology services as primary expenses.

This guideline summary, endorsed by six Spanish pediatric societies, outlines consensus recommendations for managing childhood asthma, emphasizing diagnosis, maintenance treatment with low-dose inhaled corticosteroids, and patient education for effective control.